Medicare Enrolled
Dr. Thomas McKenna, M.D.
Gastroenterology · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McKenna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McKenna?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McKenna
Dr. Thomas McKenna is a gastroenterology specialist in Bryn Mawr, PA, with 16 years of NPI registration. Based on federal Medicare data, Dr. McKenna performed 1,097 Medicare services across 1,024 unique beneficiaries.
Between the years covered by Open Payments, Dr. McKenna received a total of $13,794 from 54 pharmaceutical and/or device companies across 965 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McKenna is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 13% volume in PA
$13,794 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,097
Medicare services
Top 13% in PA for gastroenterology
1,024
Unique beneficiaries
$124
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~69 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
224 | $101 | $219 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
162 | $81 | $494 |
| New patient office visit, complex (60-74 min) | 157 | $173 | $311 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
153 | $215 | $1,037 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
130 | $80 | $689 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
90 | $142 | $310 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
74 | $65 | $176 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
33 | $186 | $633 |
| Stool test for blood A laboratory test that checks a stool sample for hidden blood using a chemical reaction. This test helps detect bleeding in the digestive tract. |
24 | $4 | $15 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
14 | $79 | $495 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $136 | $274 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
11 | $137 | $633 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
11 | $189 | $633 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,794
Total received (2018-2024)
Avg $1,971/year across 7 years
Top 14% in PA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
965
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,777 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,513
2023
$2,010
2022
$2,063
2021
$1,657
2020
$986
2019
$2,679
2018
$1,886
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$677
Takeda Pharmaceuticals U.S.A., Inc.
$303
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$248
Janssen Biotech, Inc.
$162
Celgene Corporation
$160
PFIZER INC.
$153
Lilly USA, LLC
$144
Regeneron Healthcare Solutions, Inc.
$107
IRONWOOD PHARMACEUTICALS, INC
$105
Madrigal Pharmaceuticals
$73
Phathom Pharmaceuticals, Inc.
$56
Daiichi Sankyo Inc.
$51
Celltrion USA Inc.
$48
Ardelyx, Inc.
$39
Braintree Laboratories, Inc.
$37
GENZYME CORPORATION
$33
Kerecis Limited
$26
QOL Medical, LLC
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Intercept Pharmaceuticals, Inc.
$17
Sandoz Inc.
$16
Gilead Sciences, Inc.
$15
Top 3 companies account for 48.9% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,639
ABBVIE INC.
$1,968
Takeda Pharmaceuticals U.S.A., Inc.
$1,222
AbbVie Inc.
$845
Janssen Biotech, Inc.
$719
AbbVie, Inc.
$689
Celgene Corporation
$609
PFIZER INC.
$569
UCB, Inc.
$404
Ironwood Pharmaceuticals, Inc
$298
Regeneron Healthcare Solutions, Inc.
$245
Daiichi Sankyo Inc.
$239
Amgen Inc.
$233
Gilead Sciences, Inc.
$227
Ferring Pharmaceuticals Inc.
$208
Alexion Pharmaceuticals, Inc.
$206
QOL Medical, LLC
$199
Boston Scientific Corporation
$167
Lilly USA, LLC
$144
IRONWOOD PHARMACEUTICALS, INC
$137
AstraZeneca Pharmaceuticals LP
$125
Nestle HealthCare Nutrition Inc.
$116
Janssen Scientific Affairs, LLC
$113
Synergy Pharmaceuticals Inc
$112
Intercept Pharmaceuticals, Inc.
$108
Allergan Inc.
$97
Braintree Laboratories, Inc.
$88
Bayer HealthCare Pharmaceuticals Inc.
$85
Ardelyx, Inc.
$77
Merck Sharp & Dohme Corporation
$75
Madrigal Pharmaceuticals
$73
GENZYME CORPORATION
$64
Shire North American Group Inc
$61
Enterra Medical, Inc.
$59
Phathom Pharmaceuticals, Inc.
$56
RedHill Biopharma Inc.
$54
Celltrion USA Inc.
$48
Romark Laboratories, LC
$47
Merck Sharp & Dohme LLC
$39
Shionogi Inc
$38
Aries Pharmaceuticals, Inc.
$38
BOSTON SCIENTIFIC CORPORATION
$37
VIVUS, Inc.
$28
PORTOLA PHARMACEUTICALS, LLC
$26
Kerecis Limited
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Prometheus Laboratories Inc.
$18
INTERCEPT PHARMACEUTICALS, INC.
$16
NESTLE HEALTHCARE NUTRITION INC.
$16
Sandoz Inc.
$16
Otsuka America Pharmaceutical, Inc.
$14
Alnylam Pharmaceuticals Inc.
$14
ALBIREO PHARMA, INC.
$13
Concordia Pharmaceuticals Inc.
$11
Top 3 companies account for 42.3% of all-time payments
Associated products mentioned in payments ›
ALLIANCE · AMJEVITA · ANDEXXA · APRISO · Aemcolo · Aimovig · Alinia · Amitiza · BREATHTEK · Bylvay · CIMZIA · CLENPIQ · CREON · CYLTEZO · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · Donnatal · ELEVIEW · ENTYVIO · EOHILIA · EVENITY · Entyvio · Epclusa · FARXIGA · GATTEX · GENERAL ENTERAL FEEDING · GENERAL - BILIARY DEVICES · GENERAL - ENDOCHOICE · GIVLAARI · HUMIRA · HYRIMOZ · Humira · IBSRELA · INFLECTRA · INJECTAFER · Kanuma · Kerecis Omega3 SurgiClose · Kerendia · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Motegrity · Movantik · Mulpleta · OCALIVA · OMVOH · PANCREAZE · REBYOTA · RELISTOR · RELISTOR ORAL · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · SPYGLASS · STELARA · SUCRAID · SUFLAVE · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UBRELVY · UCERIS · VEGZELMA · VIBERZI · VOQUEZNA · VOWST · WATCHMAN · WallFlex Duodenal · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
414
Per 100K population
71.9
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McKenna is a clinical cardiology specialist, with above-average Medicare volume (top 13% in PA), with low-engagement industry engagement in the top 14% of PA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McKenna experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McKenna performed 224 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McKenna receive payments from pharmaceutical companies?
Yes. Dr. McKenna received a total of $13,794 from 54 companies across 965 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McKenna's costs compare to other gastroenterologists in Bryn Mawr?
Dr. McKenna's average Medicare payment per service is $124. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McKenna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Bryn Mawr
Browse gastroenterologists in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in PA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in PA
Which PA gastroenterologists receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology